- Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: A systematic review and meta-analysis
- Efficacy of levetiracetam for neonatal seizures in preterm infants
- Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study
- The risk of acute pancreatitis after initiation of dipeptidyl peptidase 4 inhibitors: Testing a hypothesis of subgroup differences in older U.S adults
- Pain and quality of life of children and adolescents with osteogenesis imperfecta over a bisphosphonate treatment cycle
- Association of antenatal steroid and risk of retinopathy of prematurity: A systematic review and meta-analysis
- Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: A randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
- Serious infection across biologic-treated patients with rheumatoid arthritis: Results from the British society for rheumatology biologics register for rheumatoid arthritis
- Cyclophosphamide or rituximab treatment of scleritis and uveitis for patients with granulomatosis with polyangiitis
- Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma
- Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome) – Results from the European phase 3 open-label safety trial
- Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: A health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial
- Efficacy and Safety of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and moderate renal function impairment: A Systematic Review and Meta-Analysis
- Anticoagulation therapy in patients with non valvular atrial fibrillation hospitalized in the Department Of Medicine in the NOACs era
- Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
Feed Sources
